Literature DB >> 25886544

The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.

H Edmund Pigott1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25886544      PMCID： PMC4314062          DOI： 10.1177/070674371506000104

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  18 in total

1.  A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

Authors:  Andrew A Nierenberg; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Michael E Thase; Patrick J McGrath; Jonathan E Alpert; Diane Warden; James F Luther; George Niederehe; Barry Lebowitz; Kathy Shores-Wilson; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

2.  Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Authors:  Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Michael E Thase; Lori Davis; Melanie M Biggs; Kathy Shores-Wilson; James F Luther; George Niederehe; Diane Warden; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

3.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

Review 5.  Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

Authors:  Maurizio Fava; A John Rush; Madhukar H Trivedi; Andrew A Nierenberg; Michael E Thase; Harold A Sackeim; Frederic M Quitkin; Steven Wisniewski; Philip W Lavori; Jerrold F Rosenbaum; David J Kupfer
Journal:  Psychiatr Clin North Am       Date:  2003-06

6.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

7.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

8.  Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.

Authors:  Corrado Barbui; Toshiaki A Furukawa; Andrea Cipriani
Journal:  CMAJ       Date:  2008-01-29       Impact factor: 8.262

9.  Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.

Authors:  Madhukar H Trivedi
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

10.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
View more
  9 in total

1.  Problems from the past and prevention for the future.

Authors:  Scott B Patten
Journal:  Can J Psychiatry       Date:  2015-01       Impact factor: 4.356

2.  STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby!

Authors:  Raymond W Lam; Sidney H Kennedy
Journal:  Can J Psychiatry       Date:  2015-01       Impact factor: 4.356

3.  Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Authors:  Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

Review 4.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Telemental Health Collaborative Care Medication Management: Implementation and Outcomes.

Authors:  Smita Das; Jane Wang; Shih-Yin Chen; Connie E Chen
Journal:  Telemed J E Health       Date:  2021-12-22       Impact factor: 5.033

Review 6.  Depressive disorders: Treatment failures and poor prognosis over the last 50 years.

Authors:  Thomas P Blackburn
Journal:  Pharmacol Res Perspect       Date:  2019-05-03

Review 7.  Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis.

Authors:  Klaus Munkholm; Asger Sand Paludan-Müller; Kim Boesen
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

8.  Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines.

Authors:  Martin Plöderl; Michael P Hengartner
Journal:  BMC Psychiatry       Date:  2019-09-02       Impact factor: 3.630

9.  The association between social engagement and depressive symptoms in middle-aged and elderly Chinese: A longitudinal subgroup identification analysis under causal inference frame.

Authors:  Yuhui Yang; Yemian Li; Peng Zhao; Jingxian Wang; Baibing Mi; Leilei Pei; Yaling Zhao; Fangyao Chen
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.